Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
Abstract
The present disclosure provides a DNA-targeting RNA that comprises a targeting sequence and, together with a modifying polypeptide, provides for site-specific modification of a target DNA and/or a polypeptide associated with the target DNA. The present disclosure further provides site-specific modifying polypeptides. The present disclosure further provides methods of site-specific modification of a target DNA and/or a polypeptide associated with the target DNA The present disclosure provides methods of modulating transcription of a target nucleic acid in a target cell, generally involving contacting the target nucleic acid with an enzymatically inactive Cas9 polypeptide and a DNA-targeting RNA. Kits and compositions for carrying out the methods are also provided. The present disclosure provides genetically modified cells that produce Cas9; and Cas9 transgenic non-human multicellular organisms.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A bacterial cell comprising a chimeric Cas9 protein comprising a Cas9 polypeptide fused to a transcriptional activator polypeptide, wherein the Cas9 polypeptide comprises one or more mutations in a RuvC domain and/or an HNH domain.
2 . A composition comprising:
a buffer; and a single-molecule DNA-targeting RNA, or a DNA encoding the single-molecule DNA-targeting RNA, wherein the single-molecule DNA-targeting RNA has the structure:
wherein the linker is nnnn such that the single-molecule DNA-targeting RNA has the nucleotide sequence nnnnnnnnnnnnnnnnnnnnGUUUUAGAGCUAnnnnUAGCAAGUUAAAAUAAGGCUAGUCCG (SEQ ID NO: 680).
3 . The composition of claim 2 , wherein the linker is GAAA such that the single-molecule DNA-targeting RNA has the structure:
wherein “20-nt targeting seq” is nnnnnnnnnnnnnnnnnnnn.
4 . A method of cleaving a target DNA, the method comprising:
contacting a target DNA with: (a) the composition of claim 242 comprising the single molecule DNA-targeting RNA, wherein the nucleotide sequence of the single-molecule DNA-targeting RNA is GAUUUCUUCUUGCGCUUUUUGUUUUAGAGCUAGAAAUAGCAAGUUAAAAUAAGGCUAGUCCG (SEQ ID NO: 321); and (b) a Cas9 protein comprising the S. pyogenes Cas9 amino acid sequence set forth as SEQ ID NO.: 2, wherein said contacting does not take place inside of a cell, and wherein the target DNA is cleaved.Join the waitlist — get patent alerts
Track US2022119847A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.